SEC Comment Letter 0000000000-23-001331 to GOLDENWELL BIOTECH, INC. (GWLL) (CIK 0001800373) (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL) (CIK 0001800373)
Date: Feb. 9, 2023 · CIK: 0001800373 · Accession: 0000000000-23-001331
AI Filing Summary & Sentiment
File numbers found in text: 000-56275
Letter
United States securities and exchange commission logo February 9, 2023 Shuang Liu Chief Executive Officer, President, and Director Goldenwell Biotech, Inc. 2071 Midway Drive Twinsburg, OH 44087 Re:Goldenwell Biotech, Inc. Form 10-K for the Fiscal Year ended December 31, 2021 Filed April 1, 2022 File No. 000-56275 Dear Shuang Liu: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Energy & Transportation
Show Raw Text
United States securities and exchange commission logo
February 9, 2023
Shuang Liu
Chief Executive Officer, President, and Director
Goldenwell Biotech, Inc.
2071 Midway Drive
Twinsburg, OH 44087
Re:Goldenwell Biotech, Inc.
Form 10-K for the Fiscal Year ended December 31, 2021
Filed April 1, 2022
File No. 000-56275
Dear Shuang Liu:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Energy & Transportation